News

Impax, Teva settle with J&J, Alza over generic ADHD drug

BY Alaric DeArment

HAYWARD, Calif. — Two generic drug makers have settled with a subsidiary of Johnson & Johnson and another company concerning a drug used to treat attention deficit hyperactivity disorder.

Impax Labs and Teva Pharmaceuticals USA had settled a patent infringement suit with Janssen Pharmaceuticals and Alza over Concerta (methylphenidate hydrochloride) extended-release tablets in the 18-mg, 27-mg, 36-mg and 54-mg strengths.

Under the agreement, Impax and Teva will be licensed to sell generic versions of the drug starting July 14, 2013. The two companies are pursuing a strategic alliance agreement with regard to the drug.

Branded and generic versions of Concerta had sales of about $1.2 billion during the 12-month period ended in July, according to Wolters Kluwer Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

FDA approves Lannett tension headache drug

BY Alaric DeArment

PHILADELPHIA — The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

Lannett announced the approval of butalbital, acetaminophen and caffeine tablets in the 50-mg/325-mg/40-mg strength. the drug is a generic version of Watson Pharmaceuticals’ Fioricet.

Branded and generic versions of the drug had sales of $30 million during the 12-month period ended in July, including $15 million for branded Fioricet. Lannett plans to start shipping its version next month, the company said.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Flirt debuts new packaging

BY Allison Cerra

CHICAGO — A functional beverage for women has undergone a packaging revamp.

Flirt energy drink has been rolled out in a redesigned Rexam 12-oz. Sleek can. The can features enhanced graphics for a more vibrant retail presentation. The company also said its decision to use Rexam Sleek cans was their shape ties into the functionality of Flirt, and the cans are a sustainable packaging choice.

"We are pleased to continue our partnership with Flirt and help them rollout their enhanced energy drink brand," Rexam Beverage Can North America president and CEO Rich Grimley said. "Our Sleek can is the perfect packaging solution, building their brand while delivering superior recycling benefits, as well as distribution and retail display economics."

Flirt Energy Drink currently is available at select retailers across the East coast.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?